41,42 Here we show that BNT162b4 generates T cell epitopes presented on HLA-I complexes in human cell lines detectable by mass spectrometry (MS). Immunization of mice with BNT162b4 generates a robust T cell response against the N, M, and ORF1ab SARS-CoV-2 proteins when administered ...
药品名称 BNT162b2 (B.1.1.7 + B.1.617.2) 药品类别 创新药; 生物; 疫苗; 核酸 靶点 SARS-CoV-2 spike protein 作用机制 mRNA疫苗 药品简介 BNT162b2 (B.1.1.7 + B.1.617.2) is a multivalent vaccine administered as third booster injection. 研发机构 BioNTech 最高研发阶段 全球: II期...